Nurix Therapeutics, Inc. Common stock (NRIX) is a publicly traded Healthcare sector company. As of September 16, 2026, NRIX trades at $25.11 with a market cap of $2.65B and a P/E ratio of -7.11. NRIX moved +1.11% today. Year to date, NRIX is +30.89%; over the trailing twelve months it is +186.39%. Its 52-week range spans $8.18 to $28.23. Analyst consensus is strong buy with an average price target of $34.27. Rallies surfaces NRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NRIX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $25.11 |
| Market Cap | $2.65B |
| P/E Ratio | -7.11 |
| EPS | $-3.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.23 |
| 52-Week Low | $8.18 |
| Volume | 4.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $36.77M |
| Net Income | $-341.35M |
| Gross Margin | 0.00% |
11 analysts cover NRIX: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.27.